Immix Biopharma (IMMX) Assets Average (2022 - 2026)
Immix Biopharma (IMMX) posted Assets Average of $100.3 million for Q1 2026, up 60.63% sequentially from $62.5 million in Q4 2025, and up 368.39% YoY from $21.4 million in Q1 2025.
Immix Biopharma (IMMX) Assets Average (2022 - 2026) Analysis & Trends
Immix Biopharma has reported Assets Average for 5 years, with the latest figure at $100.3 million in Q1 2026.
- Quarterly Assets Average rose 368.39% year-over-year to $100.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.3 million (up 368.39% YoY) and the FY2025 annual result came in at $63.9 million, up 198.06% from the prior year.
- Assets Average grew to $100.3 million in Q1 2026 per IMMX's latest filing, from $62.5 million in the prior quarter.
- Over five years, Assets Average peaked at $100.3 million in Q1 2026 and troughed at $14.1 million in Q1 2023.
- A 5-year average of $27.7 million and a median of $19.6 million in 2022 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average sank 43.77% in 2025, then surged 368.39% in 2026.
- Over 5 years, Assets Average stood at $16.2 million in 2022, then jumped by 31.26% to $21.2 million in 2023, then gained by 13.42% to $24.0 million in 2024, then soared by 159.77% to $62.5 million in 2025, then jumped by 60.63% to $100.3 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $100.3 million, $62.5 million, and $17.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Immix Biopharma | 784.75 Mn | 784.75 Mn | - | 167.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 167.46 Mn |
| Mar 31, 2026 | 100.33 Mn |
| Dec 31, 2025 | 62.46 Mn |
| Sep 30, 2025 | 17.86 Mn |
| Jun 30, 2025 | 17.76 Mn |
| Mar 31, 2025 | 21.42 Mn |
| Dec 31, 2024 | 24.04 Mn |
| Sep 30, 2024 | 26.99 Mn |
| Jun 30, 2024 | 31.59 Mn |
| Mar 31, 2024 | 27.14 Mn |
| Dec 31, 2023 | 21.20 Mn |
| Sep 30, 2023 | 19.02 Mn |
| Jun 30, 2023 | 14.39 Mn |
| Mar 31, 2023 | 14.06 Mn |
| Dec 31, 2022 | 16.15 Mn |
| Sep 30, 2022 | 18.24 Mn |
| Jun 30, 2022 | 19.55 Mn |
| Mar 31, 2022 | 19.10 Mn |